193 related articles for article (PubMed ID: 34523962)
1. Collaboration of a Detrimental HLA-B*35:01 Allele with HLA-A*24:02 in Coevolution of HIV-1 with T Cells Leading to Poorer Clinical Outcomes.
Kuse N; Murakoshi H; Akahoshi T; Chikata T; James KL; Gatanaga H; Rowland-Jones SL; Oka S; Takiguchi M
J Virol; 2021 Nov; 95(23):e0125921. PubMed ID: 34523962
[TBL] [Abstract][Full Text] [Related]
2. Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control.
Murakoshi H; Koyanagi M; Akahoshi T; Chikata T; Kuse N; Gatanaga H; Rowland-Jones SL; Oka S; Takiguchi M
EBioMedicine; 2018 Oct; 36():103-112. PubMed ID: 30249546
[TBL] [Abstract][Full Text] [Related]
3. Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1.
Zhang Y; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Murakoshi H; Takiguchi M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699092
[TBL] [Abstract][Full Text] [Related]
4. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8
Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435
[TBL] [Abstract][Full Text] [Related]
5. Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang Y; Chikata T; Kuse N; Murakoshi H; Gatanaga H; Oka S; Takiguchi M
J Virol; 2022 Nov; 96(22):e0124822. PubMed ID: 36326273
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
7. Selection of TI8-8V mutant associated with long-term control of HIV-1 by cross-reactive HLA-B*51:01-restricted cytotoxic T cells.
Kuse N; Akahoshi T; Gatanaga H; Ueno T; Oka S; Takiguchi M
J Immunol; 2014 Nov; 193(10):4814-22. PubMed ID: 25305317
[TBL] [Abstract][Full Text] [Related]
8. Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes.
Akahoshi T; Chikata T; Tamura Y; Gatanaga H; Oka S; Takiguchi M
J Virol; 2012 Feb; 86(4):1971-81. PubMed ID: 22156528
[TBL] [Abstract][Full Text] [Related]
9. Control of HIV-1 Replication by CD8
Nguyen HT; Kuse N; Zhang Y; Murakoshi H; Maeda Y; Tamura Y; Maruyama R; Tran GV; Nguyen TV; Nguyen KV; Oka S; Chikata T; Takiguchi M
J Virol; 2022 Oct; 96(19):e0081122. PubMed ID: 36154612
[TBL] [Abstract][Full Text] [Related]
10. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals.
Hashimoto M; Kitano M; Honda K; Koizumi H; Dohki S; Oka S; Takiguchi M
Hum Immunol; 2010 Feb; 71(2):123-7. PubMed ID: 19891998
[TBL] [Abstract][Full Text] [Related]
11. Critical effect of Pol escape mutations associated with detrimental allele HLA-C*15: 05 on clinical outcome in HIV-1 subtype A/E infection.
Murakoshi H; Chikata T; Akahoshi T; Zou C; Borghan MA; Van Tran G; Nguyen TV; Van Nguyen K; Kuse N; Takiguchi M
AIDS; 2021 Jan; 35(1):33-43. PubMed ID: 33031103
[TBL] [Abstract][Full Text] [Related]
12. CD8
Murakoshi H; Zou C; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
Retrovirology; 2018 Jul; 15(1):46. PubMed ID: 29970102
[TBL] [Abstract][Full Text] [Related]
13. Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts.
Fujiwara M; Tanuma J; Koizumi H; Kawashima Y; Honda K; Mastuoka-Aizawa S; Dohki S; Oka S; Takiguchi M
J Virol; 2008 Jan; 82(1):138-47. PubMed ID: 17959671
[TBL] [Abstract][Full Text] [Related]
14. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
Willberg CB; Garrison KE; Jones RB; Meiklejohn DA; Spotts G; Liegler TJ; Ostrowski MA; Karlsson AC; Hecht FM; Nixon DF
PLoS One; 2010 Apr; 5(4):e10249. PubMed ID: 20422053
[TBL] [Abstract][Full Text] [Related]
15. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
16. Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication.
Murakoshi H; Kuse N; Akahoshi T; Zhang Y; Chikata T; Borghan MA; Gatanaga H; Oka S; Sakai K; Takiguchi M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30333175
[TBL] [Abstract][Full Text] [Related]
17. Switching and emergence of CTL epitopes in HIV-1 infection.
Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
[TBL] [Abstract][Full Text] [Related]
18. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.
Bailey JR; Williams TM; Siliciano RF; Blankson JN
J Exp Med; 2006 May; 203(5):1357-69. PubMed ID: 16682496
[TBL] [Abstract][Full Text] [Related]
19. Superimposed epitopes restricted by the same HLA molecule drive distinct HIV-specific CD8+ T cell repertoires.
Sun X; Fujiwara M; Shi Y; Kuse N; Gatanaga H; Appay V; Gao GF; Oka S; Takiguchi M
J Immunol; 2014 Jul; 193(1):77-84. PubMed ID: 24899498
[TBL] [Abstract][Full Text] [Related]
20. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
Tsai MC; Singh S; Adland E; Goulder P
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
